Holen Sie sich die Stockscreener-App
36.07
2.25%
-0.83
Handel nachbörslich:
36.01
-0.06
-0.17%
Schlusskurs vom Vortag:
$36.90
Offen:
$36.9
24-Stunden-Volumen:
9.23M
Relative Volume:
2.64
Marktkapitalisierung:
$15.59B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$1.66B
KGV:
15.68
EPS:
2.3
Netto-Cashflow:
$827.02M
1W Leistung:
+0.25%
1M Leistung:
-4.85%
6M Leistung:
+6.81%
1J Leistung:
+24.08%
1-Tages-Spanne:
$35.85
$37.28
1-Wochen-Bereich:
$35.85
$37.28
52-Wochen-Spanne:
$24.05
$38.00
Royalty Pharma Plc Stock (RPRX) Company Profile
Firmenname
Royalty Pharma Plc
Sektor
Branche
Telefon
(212) 883-0200
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Vergleichen Sie RPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
36.07 | 15.95B | 2.31B | 1.66B | 827.02M | 2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-06-03 | Herabstufung | UBS | Buy → Neutral |
| 2022-06-14 | Fortgesetzt | UBS | Buy |
| 2022-05-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-30 | Eingeleitet | Tigress Financial | Buy |
| 2020-11-09 | Hochstufung | UBS | Neutral → Buy |
| 2020-07-14 | Eingeleitet | Evercore ISI | In-line |
| 2020-07-13 | Eingeleitet | BofA Securities | Buy |
| 2020-07-13 | Eingeleitet | Citigroup | Neutral |
| 2020-07-13 | Eingeleitet | Cowen | Outperform |
| 2020-07-13 | Eingeleitet | Goldman | Neutral |
| 2020-07-13 | Eingeleitet | JP Morgan | Neutral |
| 2020-07-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Eingeleitet | SunTrust | Buy |
| 2020-07-13 | Eingeleitet | UBS | Neutral |
Alle ansehen
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
How to interpret RSI for Royalty Pharma plc stockMarket Movers & Risk Controlled Stock Alerts - Newser
Ieq Capital LLC Boosts Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
What MACD and RSI say about Royalty Pharma plcWeekly Market Outlook & Precise Buy Zone Tips - Newser
strategies to average down on royalty pharma plcJuly 2025 Gainers & Free Real-Time Volume Trigger Notifications - Newser
Applying sector rotation models to Royalty Pharma plc2025 Price Targets & Safe Entry Zone Tips - Newser
Will Royalty Pharma plc continue its uptrend2025 Volatility Report & Fast Exit and Entry Trade Guides - Newser
Royalty Pharma PLC $RPRX Shares Sold by AlTi Global Inc. - MarketBeat
Applying Wyckoff theory to Royalty Pharma plc stockJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser
Will breakout in Royalty Pharma plc lead to full recovery2025 Key Lessons & Detailed Earnings Play Alerts - Newser
Royalty Pharma PLC $RPRX Position Boosted by American Century Companies Inc. - MarketBeat
GMT Capital Corp Has $74.01 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
Can technical indicators confirm Royalty Pharma plc’s reversal - Newser
Royalty Pharma PLC $RPRX Stock Position Increased by OMERS ADMINISTRATION Corp - MarketBeat
Strategies to average down on Royalty Pharma plcGap Up & Breakout Confirmation Trade Signals - Newser
Intraday pattern recognizer results for Royalty Pharma plcPortfolio Performance Report & AI Based Trade Execution Alerts - Newser
Wall Street Zen Upgrades Royalty Pharma (NASDAQ:RPRX) to Buy - MarketBeat
Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - The Manila Times
Leading Biopharma Royalty Investor Royalty Pharma to Join Morgan Stanley Healthcare Conference Sept 9 - Stock Titan
Magnetar Financial LLC Buys Shares of 161,496 Royalty Pharma PLC $RPRX - MarketBeat
Adage Capital Partners GP L.L.C. Trims Holdings in Royalty Pharma PLC $RPRX - MarketBeat
What does recent volatility data suggest for Royalty Pharma plc2025 Geopolitical Influence & Community Verified Trade Signals - Newser
Royalty Pharma plc stock outlook for YEARDollar Strength & Low Drawdown Momentum Trade Ideas - Newser
Royalty Pharma plc stock prediction for this weekJuly 2025 Closing Moves & Free Safe Entry Trade Signal Reports - Newser
Evergreen Capital Management LLC Has $453,000 Stake in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc a candidate for recovery playJuly 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Short interest data insights for Royalty Pharma plcM&A Rumor & Low Risk Entry Point Tips - Newser
Walleye Capital LLC Decreases Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc stock volume spike explainedQuarterly Profit Review & Verified Momentum Watchlists - Newser
What Fibonacci levels say about Royalty Pharma plc reboundPrice Action & Weekly Market Pulse Alerts - Newser
Using economic indicators to assess Royalty Pharma plc potentialJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser
Royalty Pharma plc stock trendline breakdown2025 Biggest Moves & Trade Opportunity Analysis Reports - Newser
Will Royalty Pharma plc benefit from macro trendsJuly 2025 Outlook & Long-Term Safe Investment Ideas - Newser
Combining machine learning predictions for Royalty Pharma plcMarket Activity Summary & Daily Entry Point Trade Alerts - Newser
Will Royalty Pharma plc stock recover after recent drop2025 Volatility Report & Growth Focused Entry Point Reports - Newser
How to recover losses in Royalty Pharma plc stockDollar Strength & Weekly Setup with ROI Potential - Newser
Is Royalty Pharma plc currently under institutional pressure2025 Pullback Review & Long-Term Investment Growth Plans - خودرو بانک
Compound Planning Inc. Acquires New Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc stock forming a cup and handleJuly 2025 Action & Free High Accuracy Swing Entry Alerts - خودرو بانک
Is Royalty Pharma plc still worth holding after the dipQuarterly Performance Summary & Accurate Technical Buy Alerts - Newser
How to monitor Royalty Pharma plc with trend dashboardsQuarterly Earnings Report & Expert Curated Trade Ideas - Newser
BNP Paribas Financial Markets Sells 621,864 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by Canada Pension Plan Investment Board - MarketBeat
Will Royalty Pharma plc benefit from AI trends2025 Volatility Report & Capital Protection Trading Alerts - خودرو بانک
Royalty Pharma prices $2 billion senior unsecured notes offering - StreetInsider
Is a relief rally coming for Royalty Pharma plc holders2025 Market WrapUp & Safe Entry Point Identification - Newser
Royalty Pharma Prices $2 Billion Debt Offering - MarketScreener
Zenas BioPharma secures $300M funding from Royalty Pharma for obexelimab royalties. - AInvest
Royalty Pharma plc Announces Pricing of $2.0 Billion of Senior Unsecured Notes - MarketScreener
Is Royalty Pharma plc forming a reversal patternMarket Risk Summary & Weekly High Potential Stock Alerts - Newser
Technical signs of recovery in Royalty Pharma plc2025 Big Picture & Free Safe Capital Growth Stock Tips - Newser
Royalty Pharma prices $2B senior unsecured notes - MSN
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):